⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001880600

Boyle Kevin S. Sr.

Reports to the SEC for 1 company · BOSTON, MA

Transactions

8

Companies

1

Filings

6

CIK

0001880600

Forms 4 and 5

Insider transactions

8 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-09-01	TCRTAlaunos Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−68K sh	$0.14	−$9,542.364	798,236
2023-03-15	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+1.8M sh	—	—	1,800,000
2022-08-30	TCRTAlaunos Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−18.8K sh	$2.41	−$45.2K	866,250
2022-03-30	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+2M sh	—	—	2,000,000
2021-11-17	TCRTAlaunos Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+9,116 sh	$1.40	+$12.8K	885,000
2021-11-16	TCRTAlaunos Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+884 sh	$1.40	+$1,237.6	875,884
2021-08-30	TCRTAlaunos Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+875K sh	—	—	875,000
2021-08-30	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+2.63M sh	—	—	2,625,000

Recent filings

6

Accepted (ET)
Sep 54
Boyle Kevin S. Sr.0000950170-23-046504
SEC(opens sec.gov)
Mar 174
Boyle Kevin S. Sr.0000899243-23-009000
SEC(opens sec.gov)
Sep 14
Boyle Kevin S. Sr.0000899243-22-030186
SEC(opens sec.gov)
Apr 14
Boyle Kevin S. Sr.0000899243-22-013119
SEC(opens sec.gov)
Nov 174
Boyle Kevin S. Sr.0001209191-21-065138
SEC(opens sec.gov)
Aug 314
Boyle Kevin S. Sr.0001209191-21-054089
SEC(opens sec.gov)

Companies

1

Alaunos Therapeutics, Inc.Director, Chief Executive OfficerTCRT

Address

C/O ZIOPHARM ONCOLOGY, INC. ONE FIRST AVENUE, PARRIS BLDG 34

BOSTON, MA, 02129